Department of Gastroenterology, California Pacific Medical Center.
Division of Hepatology, Department of Advanced Organ Therapies, California Pacific Medical Center.
Clin Liver Dis. 2024 May;28(2):225-236. doi: 10.1016/j.cld.2024.01.003. Epub 2024 Jan 30.
Hepatic encephalopathy (HE) remains both a clinical diagnosis and one of exclusion. Laboratory testing is largely focused on identifying precipitating factors. Ammonia levels in the blood can be helpful for the diagnosis of HE but are not required for confirmation. More recent literature is lending support to the prognostic capabilities of ammonia in cirrhosis, both in predicting future HE events and in determining outcomes in hospitalized patients. Accurate ammonia testing requires strict protocols to avoid common pitfalls in the measurement of this labile analyte. Future studies investigating the utility of other laboratory testing to diagnose, stage, or predict HE are encouraged.
肝性脑病(HE)仍然既是一种临床诊断,也是一种排除诊断。实验室检测主要集中在确定诱发因素上。血液中的氨水平有助于 HE 的诊断,但并非确诊所必需。最近的文献支持氨在肝硬化中的预后能力,包括预测未来的 HE 事件和确定住院患者的结局。准确的氨检测需要严格的方案,以避免在测量这种不稳定分析物时常见的陷阱。鼓励开展进一步的研究,以探讨其他实验室检测在诊断、分期或预测 HE 中的作用。